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Insulin/insulin-like growth factor type 1 signaling regulates lifespan and resistance to oxidative stress in worms, ﬂies, and
mammals. In a previous study, we revealed that insulin receptor (IR) mutant mice, which carry a homologous mutation found
in the long-lived daf-2 mutant of Caenorhabditis elegans, showed enhanced resistance to oxidative stress cooperatively modulated
by sex hormones and dietary signals (Baba et al., (2005)). We herein investigated the lifespan of IR mutant mice to evaluate the
biological signiﬁcance of insulin signaling in mice. Under normoxia, mutant male mice had a lifespan comparable to that of wild-
type male mice. IR mutant female mice also showed a lifespan similar to that of wild-type female mice, in spite of the fact that
the IR mutant female mice acquired more resistance to oxidative stress than IR mutant male mice. On the other hand, IR mutant
male and female mice both showed insulin resistance with hyperinsulinemia, but they did not develop hyperglycemia throughout
their entire lifespan. These data indicate that the IR mutation does not impact the lifespan in mice, thus suggesting that insulin
signaling might have a limited eﬀect on the lifespan of mice.
1.Introduction
Accumulating evidence indicates that insulin/insulin-like
growth factor type 1 (IGF-1) signaling regulates lifespan in
worms, ﬂies, and mammals [1, 2]. In Caenorhabditis elegans,
am u t a t i o no ft h edaf-2 gene that encodes an insulin/IGF-
1 receptor ortholog signiﬁcantly extended the lifespan and
enhanced the resistance of the worms to oxidative stress
[3, 4]. The lifespan extension caused by daf-2 mutations
required the activity of daf-16 [3], which encodes a FOXO
family transcription factor [5, 6]. Insulin/IGF-1 receptor
mutations can also increase the lifespan of Drosophila [7]. In
addition, mutations in chico, a downstream insulin receptor
(IR) substrate-like signaling protein, increased the lifespan
of the ﬂies [8]. In mice, long-lived hereditary dwarf mice
have been described [9]. Low levels of circulating growth
hormone (GH) and IGF-1 in the Ames and Snell dwarf
mice, which have pituitary defects, were associated with
an extension of their lifespan [9]. Mutations in upstream
genes that regulate insulin and IGF-1 also extended lifespan.
For example, Little mice harbor a mutation in the GH-
releasing hormone receptor and display reduced GH, as well
as prolactin secretion [10]. Little mice also show reduced
IGF-1 in blood, and have an increased mean and maximal
lifespan [9]. Furthermore, GH receptor (GHR) mutant mice
showed reduced circulating IGF-1 levels and an increased
lifespan [11].
Although insulin/IGF-1 signaling controls the lifespan
in mice, global deletion of insulin or IGF-1 causes early
lethality associated with severe growth retardation. Mice
lacking two nonallelic insulin genes, Ins1 and Ins2, died
in the early postnatal stage [12], while more than 95% of
IGF1-nullmicediedperinatally[13].Unlikewormsandﬂies,
which have a single insulin/IGF-1-like receptor, mice have
separate receptors for insulin and IGF-1. Mice with a global
deletion of either the IR or the IGF-1 receptor (IGF-1R) gene2 Journal of Aging Research
showed early postnatal lethality [14–16]. However, female
mice with a heterozygous deletion of the IGF-1R displayed
a 26% increase in mean lifespan [17]. IGF-1R heterozygous
mice also showed mild growth retardation, but normal IGF-
1 levels, as well as enhanced resistance to oxidative stress.
In addition, mice that lack the IR gene in adipose tissue
(FIRKO) live signiﬁcantly longer than wild-type mice [18].
In a previous study, we generated a homologous murine
model by replacing the Pro1195 of IR with Leu1195 using a
targeted knock-in strategy to investigate the biological sig-
niﬁcance of longevity mutations found in the daf-2 mutant
of C. elegans [19]. The homozygous mice died during the
neonatal stage from diabetic ketoacidosis [19, 20], which was
consistent with the phenotypes of IR-deﬁcient mice [14, 16].
On the other hand, heterozygous mice showed suppressed
kinase activity of the IR, but they grew normally without
spontaneously developing hyperglycemia during adulthood.
Furthermore, we demonstrated that IR mutant (IrP1195L/wt)
mice acquired an enhanced resistance to oxidative stress,
such as exposure to 80% oxygen or paraquat. We also
revealed that gender diﬀerences and dietary restriction are
also associated with the defective insulin signaling [19].
In the present study, we investigated the lifespan of
IrP1195L/wt male and female mice under normoxia to clarify
the insulin signaling resulting from a homologous muta-
tion of daf-2 as a determinant of mammalian lifespan.
Furthermore, we investigated the pathological consequences
of the IR mutation related to systemic insulin resistance,
because insulin signaling is generally regulated to the glucose
metabolisminmammals.WehereinrevealthattheIrP1195L/wt
mice showed a normal lifespan and did not develop hyper-
glycemia, as is seen in diabetes mellitus (DM) patients.
2.MaterialsandMethods
2.1. Animals. IrP1195L/wt mice [19] were backcrossed to
C57BL6/NCrSlc mice (Japan SLC, Hamamatsu, Japan) for
ﬁve or six generations. Mice were housed in speciﬁc
pathogen-free facilities on a 12h light/dark cycle (0800 on,
2000 oﬀ) and were fed an autoclaved standard chow (CRF-
1; Oriental Yeast, Tokyo) and water ad libitum.T h ec h o w
consisted of 54.5% (wt/wt) carbohydrate, 5.7% (wt/wt) fat,
22.4% (wt/wt) protein, and 3.1% (wt/wt) dietary ﬁber.
Food intake was measured on a monthly basis until death.
For measurement of the reproduction rate, we mated
females with fertile males for four weeks at sexual maturity,
and recorded the resulting pregnancies and oﬀsprings.
For measurement of rectal temperature, we used a digital
thermometer with a rectal probe (BDT-100, Bio Research
Center, Nagoya, Japan). All protocols for animal use and
experiments were reviewed and approved by the Animal
Care Committee of the Tokyo Metropolitan Institute of
Gerontology.
2.2. Lifespan Determination. By mating IrP1195L/wt males or
females with 8- to 20-week-old C57BL6/NCrSlc males or
females,wegeneratedtwocohortscomposedof42IrP1195L/wt
males and 64 Irwt/wt males, and 50 IrP1195L/wt females and 60
Irwt/wt females. Male or female mice were randomly divided
into four mice per a regular cage. We checked the mice daily
and counted the number of dead mice. The body weights of
mice were measured at 4-week intervals from 4-weeks after
birth until death.
2.3. Histopathological Analysis. Mice were sacriﬁced via
cervical dislocation. The pancreas was removed and ﬁxed
with mild formalin solution, and tissue samples were
embedded in paraﬃn. Four-μm-thick sections were stained
with hematoxylin and eosin.
2.4. Glucose Metabolism. The blood glucose concentrations
weredeterminedinfastingmice(3-,12-,18-,and25-months
old) using an automatic monitor, the Glucocard (Arkray,
Kyoto, Japan). The serum insulin levels were measured in 4-,
9-, and 25-month-old mice. Serum obtained from nonfast-
ing or fasting mice was analyzed for insulin using a Mouse
Insulin ELISA kit (Shibayagi, Shibukawa, Japan). During
glucose tolerance tests, mice fasted overnight and then
received intraperitoneally injections of 2g/kg body weight
of 20% D-glucose. The blood glucose concentrations were
determined in whole blood obtained from the tail at 0, 15,
30, 60, and 120 minutes after the glucose injection. For the
insulin tolerance tests, mice were injected intraperitoneally
with 1U/kg body weight of insulin (Eli Lilly, Indianapolis),
then the blood glucose concentrations were measured at
0, 15, 30, and 60 minutes after the injection. The serum
adiponectin concentrations were measured in nonfasting
mice (4-month-old) using a Mouse/Rat Adiponectin ELISA
kit (Otsuka Pharmaceutical, Tokyo, Japan).
2.5. Adipose Tissues and Bone Examination. Mice were
sacriﬁced at 20 months of age and scanned three times
usingaLunarPIXImus2densitometer(GEHealthcareLunar,
Madison, Wis, USA). All mice were fasted for 3 hours before
the DEXA.
2.6. Respirometry Monitoring using Metabolic Cages. Oxygen
consumption (VO2) and carbon dioxide excretion (VCO2)
values were measured in 5-month-old male mice (n = 3)
using an O2/CO2 metabolism measuring system for small
animals (MK-5000RQ, Muromachi Kikai). The mice were
isolated in a semisealed cage, and the inner air was aspirated
at a constant volume/min (approx., 0.65–0.70l/min). The
concentrations of O2 and CO2 in the aspirated air were mea-
sured per minute at intervals of 3 minutes, and automatically
corrected using standard O2 and CO2 values. The respiratory
quotient (RQ) values were calculated by the VCO2/VO2.
3. Results
3.1. IrP1195L/wt Mice Have a Normal Lifespan. In order to
evaluate the lifespan of IrP1195L/wt mice, we compared the
50% survival and maximum lifespan of IrP1195L/wt mice with
those of wild-type (Irwt/wt) mice. As shown in Figure 1(a),
the IrP1195L/wt male mice failed to show an extended lifespan
compared to the Irwt/wt male mice. Likewise, the IrP1195L/wt
female mice also failed to show any increase in survivalJournal of Aging Research 3
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Figure 1: The survival curves and body weights of Ir
P1195L/wt mice. (a) The Kaplan-Meier survival curves of Ir
P1195L/wt male (n = 42) and
Irwt/wt male (n = 64) mice (generalized Wilcoxon test, P = 0.33). Bold and thin lines indicate Ir
P1195L/wt and Irwt/wt mice, respectively. (b)
The Kaplan-Meier survival curves of Ir
P1195L/wt female (n = 50) and Irwt/wt female (n = 60) mice (generalized Wilcoxon test, P = 0.42).
(c, d) The body weights of male (c) and female (d) mice. The Ir
P1195L/wt male mice (n = 28) showed signiﬁcantly decreased body weight
compared to that of Irwt/wt male mice (n = 36) from 9 to 25 months of age, while the Ir
P1195L/wt female mice (n = 39) failed to show any
signiﬁcant diﬀerence compared to the Irwt/wt female mice (n = 47). Closed triangles and closed diamonds indicate Ir
P1195L/wt and Irwt/wt
mice, respectively.
comparedtotheIrwt/wt femalemice(Figure 1(b)).AKaplan-
Meier analysis showed that the 50% survival of IrP1195L/wt
male and Irwt/wt male mice was 883 days (29.0 months)
and 855 days (28.1 months), respectively (Figure 1(a)). In
females, the 50% survival of IrP1195L/wt and Irwt/wt mice
was 863 days (28.4 months) and 856 days (28.1 months),
respectively (Figure 1(b)). The maximum lifespans of the
Irwt/wt male and female mice were 1,144 days (37.6 months)
and 1,226 days (40.3 months), respectively. Those of the
IrP1195L/wt male and female mice were 1,092 days (35.9
months) and 1,126 days (37.0 months), respectively (Figures
1(a) and 1(b)). The results demonstrated that the introduc-
tion of an IR mutation does not extend the lifespan of male
and female mice (Figures 1(a) and 1(b)).
Since the IrP1195L/wt male and female mice exhibited a
reduction in body weight at 4 months of age compared to
the wild type mice [19], we measured the body weight from
1 to 32 months. The body weight of IrP1195L/wt male mice
was lower than that of the Irwt/wt mice from 9 months to 25
months,whiletheIrP1195L/wt femalemicefailedtoexhibitany
diﬀerence in body weight compared to the wild-type mice
throughout their entire lifespan (Figures 1(c) and 1(d)).
3.2. IrP1195L/wt Mice Exhibit Hyperinsulinemia but Do Not
Develop Hyperglycemia. In order to determine whether the
suppression of IR signaling impairs glucose metabolism
in aged male and female mice, we measured the blood
glucose (Figure 2(a)) and serum insulin (Figures 2(b) and
2(c)) levels in the IrP1195L/wt male and female mice. In
a fasting condition, the IrP1195L/wt male and female mice
did not develop hyperglycemia at any point throughout
their entire lifespan (3 to 25 months of age, Figure 2(a)).
However, the serum insulin concentrations in the non-
fasting state were signiﬁcantly increased in 4- and 9-month-
old male and female mutant mice compared to Irwt/wt
mice (Figure 2(b)). Furthermore, we also found increased
insulin concentrations in aged IrP1195L/wt males and females
comparedtotheIrwt/wt maleandfemalemiceunderafasting4 Journal of Aging Research
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Figure 2: The blood glucose and serum insulin concentrations in Ir
P1195L/wt mice. (a) The blood glucose concentrations of fasting mutant
male and female mice were assessed. All Ir
P1195L/wt mice exhibited blood glucose concentrations within the same range as the Irwt/wt mice
(n = 6–10 for each genotype). (b) The serum insulin concentrations were determined in the nonfasting state of 4- and 9-month-old Irwt/wt
and Ir
P1195L/wt mice (n = 7 for each genotype). (c) The serum insulin concentrations were determined in the fasting state of 25-month-old
Irwt/wt and Ir
P1195L/wt mice (n = 5 for each genotype). The insulin concentrations were signiﬁcantly increased in both female and male
Ir
P1195L/wt mice compared with the Irwt/wt mice. (d, e) The histochemical analyses of the pancreas of Ir
P1195L/wt mice. (d) The Ir
P1195L/wt male
mice exhibited extensive enlargement of the Langerhans islets compared to Irwt/wt mice. (e) In addition, the size of islets in Ir
P1195L/wt female
mice was larger than in Irwt/wt female mice. The scale bars indicate 200μm. ∗P<0.05, ∗∗P<0.005 by Student’s t-test.
condition (Figure 2(c)). Although we failed to detect any
gender diﬀerences in the insulin concentrations of Irwt/wt
mice, the insulin concentrations of aged IrP1195L/wt males
were signiﬁcantly increased compared to aged IrP1195L/wt
females (Figures 2(b) and 2(c)). The histological analysis
showed the enlargement of Langerhans islets in the pancreas
of IrP1195L/wt mice at 6 and 12 months of age (Figures 2(d)
and 2(e)). In particular, IrP1195L/wt male mice exhibited an
extensive hyperplasia of the islets. These results suggest that
aged IrP1195L/wt mice maintained hyperinsulinemia, due to
the proliferation of β-cells in islets, and did not develop
hyperglycemia during aging.
Inordertodeterminethephysiologicalcompensationfor
the mutation of the IR gene, we assessed the glucose and
insulin tolerances of IrP1195L/wt mice at 18 months of age. We
previously reported that young IrP1195L/wt male mice showed
glucose intolerance and reduced insulin sensitivity, while
IrP1195L/wt females did not show these tolerances, in spite of
hyperinsulinemia [19]. In the glucose tolerance test, the 18-
month-old IrP1195L/wt male and female mice both showed a
normal glucose tolerance (Figures 3(a) and 3(b)). On the
other hand, aged IrP1195L/wt male mice had impaired insulin
sensitivity (Figure 3(c)), while aged IrP1195L/wt females and
Irwt/wt females reacted similarly to insulin administration
(Figure 3(d)).Basedonthedataaboutglucosemetabolismin
young and aged mice, we suggested thatIrP1195L/wt male mice
maintained reduced insulin sensitivity during aging, but that
the IrP1195L/wt female mice did not.Journal of Aging Research 5
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Figure 3: The results of the glucose and insulin tolerance tests in aged Ir
P1195L/wt mice. (a, b) Glucose tolerance tests were performed on
18-month-old Irwt/wt and Ir
P1195L/wt mice (n = 5 for each genotype). (c, d) Insulin tolerance tests were performed on 18-month-old Irwt/wt
and Ir
P1195L/wt mice (n = 5i ne a c hg e n o t y p e ) .∗P<0.05 by Student’s t-test.
3.3. IrP1195L/wt Mice Show a Reduction of Adipose Tissue
and Enhancement of Bone Density. In the previous study,
we showed a reduction of perigonadal adipose tissues in
IrP1195L/wt male and female mice [19]. To assess the overall
distribution of adipose tissues in mutant mice at 20 months
of age, we measured the adipose mass by dual-energy
X-ray absorptiometry (DEXA). The IrP1195L/wt male and
female mice showed a signiﬁcantly reduced adipose mass
(Figure 4(a)). Since the circulating adiponectin levels
negatively correlate with visceral adiposity in humans [21],
we measured the serum adiponectin concentrations in
non-fasting IrP1195L/wt mice. The adiponectin concentrations
in the IrP1195L/wt mice were not increased compared toIrwt/wt
mice (male; 23.7 ± 2.8 versus 27.0 ± 7.6 μg/mL, female; 44.8
± 5.0 versus 42.3 ± 3.3 μg/ml, resp.,) at 4 months of age,
suggesting that the reduced adiposity induced by altered IR
signaling might be insuﬃcient to enhance the secretion of
adiponectin from adipose tissues in IrP1195L/wt mice.
Since osteoblasts and adipocytes are diﬀerentiated from
common progenitor cells in the bone marrow [22–24], we
assumed that the common progenitor cells of IrP1195L/wt
mice had diﬀerentiated into osteoblasts, which would lead
to enhanced bone formation instead of generating adipose
tissue in these mice. The DEXA analysis demonstrated that
there was a signiﬁcant increase in the bone density in aged
IrP1195L/wt mice (Figure 4(b)). Interestingly, 4-month-old6 Journal of Aging Research
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Figure 4: Adiposity, bone density, food intake, reproduction, rectal temperature, and respiratory quotients of the Ir
P1195L/wt mice. (a) Both
male and female Ir
P1195L/wt mice showed a signiﬁcantly decreased fat ratio compared to Irwt/wt mice at 20 months of age. (b) Both male and
female Ir
P1195L/wt mice showed signiﬁcantly increased bone density compared to the Irwt/wt mice at 20 months of age. Aged Ir
P1195L/wt male
(n = 6), Ir
P1195L/wt female (n = 6), Irwt/wt male (n = 6), and Ir
wt/wt female (n = 5) mice were evaluated by DEXA. (c) The food intake of
Ir
P1195L/wt male and Ir
wt/wt male mice at 4, 11, and 17 months of age. No signiﬁcant diﬀerence was observed between the food consumption
by Ir
P1195L/wt (n = 10) and Ir
wt/wt (n = 12) mice. (d) The reproduction rate of Ir
P1195L/wt female mice. No signiﬁcant diﬀerence was observed
between Ir
P1195L/wt and Ir
wt/wt mice (at least 3 mice per genotype). (e) The rectal temperatures of Ir
P1195L/wt and Ir
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P1195L/wt and Ir
wt/wt mice (n = 4f o re a c hg e n o t y p e ) .
∗P<0.05, ∗∗P<0.005 by Student’s t-test. (f) The mean time course of respiratory quotients (RQ = VCO2/VO2) of male mice at 5 months
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IrP1195L/wt mice failed to exhibit any signiﬁcant diﬀerence in
bone density compared to 4-month-old Irwt/wt mice (data
notshown). Theseresultssuggestedthatoneofthebeneﬁcial
eﬀects of the IrP1195L/wt genotype in the later stage of life
is due to the reduction of adipose mass associated with the
enhancement of bone density.
3.4. IrP1195L/wt Mice Show Normal Food Intake, Reproduction
Rates, Rectal Temperatures, and Metabolism. Since dietary
restriction can prolong the lifespan of animals [25], we
compared the food intake of IrP1195L/wt mice with that of
Irwt/wt mice. We failed to detect any signiﬁcant diﬀerence
in food intake between the IrP1195L/wt and Irwt/wt mice
(Figure 4(c)), suggesting that dietary restriction did not
aﬀect the lifespan of the IrP1195L/wt mice. Since long-lived
dwarf mice display reduced fecundity [9], we measured the
reproduction rate in IrP1195L/wt female mice. As shown in
Figure 4(d), the results indicated that the IrP1195L/wt mice
reproduced to generate a number of pups comparable to the
number produced by Irwt/wt female mice.
A relationship between low body temperature and lifes-
pan has been reported in long-lived Ames dwarf mice and
rhesusmonkeysondietaryrestriction[26–28].Therefore,we
measuredtherectaltemperatureofIrP1195L/wt mice.Wefailed
todetectanysigniﬁcantdiﬀerencesintherectaltemperatures
between IrP1195L/wt and Irwt/wt mice (Figure 4(e)). Since
metabolism may have an important role in aging, we
also analyzed voluntarily running distance to evaluate the
physical activity in IrP1195L/wt mice. However, we did not
observe any substantial diﬀerences in running distance for
14 days between IrP1195L/wt male and Irwt/wt male mice
(data not shown). We also measured the VO2 and VCO2
of the mice in metabolic cages. Although the respiratory
quotient value of the IrP1195L/wt males was slightly increased
in the light phase, the IrP1195L/wt mice showed comparable
metabolism to Irwt/wt male mice (Figure 4(f)). These results
suggested that the IrP1195L/wt mice did not have modulation
in their metabolism, such as reduced food intake, lower body
temperature, or any diﬀerences in their physical activity,
respiratory quotient, or reproductive activities.
4. Discussion
4.1. The Biological Roles of Insulin Signaling in Adipose Tissue
for Lifespan Extension. Bluher et al. reported that speciﬁc
deletion of the IR gene in adipose tissues extended the
lifespan of FIRKO mice [18]. FIRKO mice also showed
reducedadiposity, aswellasnormalfoodintake.Theauthors
suggested in that paper that leanness, not dietary restriction,
is a key contributor to an extended lifespan [18]. Since
IR signaling was completely downregulated in the adipose
tissues of FIRKO mice, but was normal in other tissues, the
loss of insulin signaling might confer a reduction of fat mass
in adipose tissues. In the present study, we observed that
the IrP1195L/wt mice displayed a reduction in fat mass with
normal food intake (Figures 4(a) and 4(d)), indicating that
the IrP1195L/wt mice showed similar phenotypes to the FIRKO
mice with respect to their adiposity. However, the IrP1195L/wt
mice failed to show an extended lifespan, in contrast to
the FIRKO mice (Figures 1(a) and 1(b)). Although the
diﬀerences in the beneﬁcial eﬀects on lifespan in these
mutant mice is still unclear, we believe that there are three
possible reasons for these diﬀerences, as described below.
First, the reduced fat mass in IrP1195L/wt mice was not
suﬃcient to extend the lifespan of these mice, while the
reduced level in the FIRKO mice was suﬃcient to produce a
lifespan change. In fact, we failed to observe any diﬀerence in
the serum adiponectin concentration between the IrP1195L/wt
and wild-type mice. Second, in contrast to the IR mutation
of IrP1195L/wt mice, the IR insuﬃciency, speciﬁcally in the
adipose tissues of the FIRKO mice, might modulate their
lifespanbyanindependentmechanism.Theinsulinsignaling
in adipose tissues of FIRKO mice might promote the
diﬀerential regulation of the biosynthesis of adipokines such
as adiponectin, leptin, tumor-necrosis factor-α, resistin, and
retinol binding protein-4. Third, FIRKO mice exhibited
tissue-speciﬁc reduced insulin signaling in adipose tissues.
In contrast, global insulin resistance due to a systemic IR
mutation might inhibit the beneﬁcial eﬀects of a reduced fat
mass on lifespan extension in mice.
4.2. IGF-1 Receptor Signaling May Dominantly Regulate the
Lifespan in Mice. It is unclear whether the IR or IGF-1R
corresponds to the function of daf-2 in C. elegans with
regard to the lifespan regulation in vertebrates. Holzenberger
et al. reported that both male and female IGF-1R gene
heterozygousmiceshowedanextendedlifespan,withnormal
fertility, and that they also showed an increased resistance to
oxidative stress [17]. Since the mutation introduced in the
IR gene presented in this paper showed a dominant negative
eﬀect, and the tyrosine kinase activities were severely down-
regulated, it is diﬃcult to directly compare its phenotype
with IGF-1R-deﬁcient mice that show haploinsuﬃciency
in IGF-1R signaling. Although decreased IGF-1R signaling
prolonged the lifespan in IGF-1R mutant mice, altered IR
signaling failed to extend the lifespan in IrP1195L/wt mice.
Another line of evidence for the importance of IGF-1R
signaling in lifespan regulation is that long-lived dwarf
mice display low levels of GH and circulating IGF-1 [29,
30]. Furthermore, targeted inactivation of the GH receptor
also showed a decrease in the circulating IGF-1 level, and
increased lifespan [11]. These results revealed that IGF-1
signaling might dominantly regulate the lifespan in mice,
while insulin signaling might mainly regulate glucose and
energy metabolism, rather than lifespan.
4.3. Comparison of Ir Mutant Mice with Other Long-Lived
Mutant Mice, Including Klotho Tg, Irs1, Irs2, and S6K Mutant
Mice, on Lifespan Extension. Kurosu et al. reported that
overexpression of the Klotho gene extends the lifespan in
male and female mice [31]. Two lines of Klotho Tg mice also
showed reduced fecundity in females and insulin resistance
in both genders. When the soluble Klotho protein was
intraperitoneally administered to wild-type mice, the insulin
and IGF-1 sensitivity of the mice was impaired, indicating
that increased Klotho protein in the blood induced insulin
resistance, as well as IGF-1 resistance. Since the IrP1195L/wt
micealsoshowedinsulinresistance,butnotIGF-1resistance,8 Journal of Aging Research
IGF-1 resistance might be necessary for the lifespan exten-
sion in mice. This result is consistent with the reduced IGF-1
signaling observed in Igf1r +/− and long-lived dwarf mice.
Recently, Taguchi et al. and Selman et al. reported that
mice with mutations in Irs1 and Irs2, components of the
insulin/IGF-1 signaling pathway, showed an extended lifes-
panandreducedinsulinsensitivity[32,33].Selmanetal.also
reported that deletion of ribosomal S6 protein kinase (S6K),
acomponentofthenutrient-responsivemTOR(mammalian
target of rapamycin) signaling pathway, led to an increased
lifespan and loss of insulin sensitivity [34]. Taken together
with these reports, our results suggest that reduced insulin
sensitivity has a limited eﬀect on the lifespan in mice.
4.4. Oxidative Stress and Lifespan in IrP1195L/wt Mice. Long-
livednematodeandﬂymutantswithalteredinsulinsignaling
generallyacquireenhancedresistancetooxidativestress[3,7,
8, 35]. Furthermore, long-lived dwarf, Igf1r +/−,a n dp 6 6 shc-/-
micealsoshowedenhancedresistancetoparaquat[9,17,36].
In our previous study, we reported that IrP1195L/wt male and
female mice also showed signiﬁcantly enhanced resistance
to oxidative stress, such as hyperoxia and paraquat [19].
Furthermore, IrP1195L/wt female mice survived longer than
IrP1195L/wt male mice in an 80% oxygen chamber, suggesting
that sex hormones modulate the resistance to oxidative stress
in mice. We also demonstrated that estrogen modulated
the resistance to oxidative stress by estrogen administration
in male and ovariectomy in female mice. In the present
study, however, the IrP1195L/wt female mice failed to show any
increase in survival under normoxia (Figure 1(c)). Likewise,
the IrP1195L/wt male mice showed a normal lifespan (Figures
1(a) and 1(b)). These results indicate that the resistance to
oxidative stress is not correlated with the lifespan in mice.
Although we are unable to exclude the possibility that other
limitingfactorsmodulatedthelifespaninIrP1195L/wt mice,we
suggest that the enhanced resistance to oxidative stress is not
a major determinant for lifespan extension in mice.
4.5. IrP1195L/wtMice Show a Normal Lifespan, without Devel-
oping Hyperglycemia. Mutations in the IR gene cause
insulin resistance syndromes, such as leprehaunism, Rabson-
Mendenhallsyndrome,andtypeAinsulinresistance[37,38].
We introduced a mutation substituting a Leu1195 for the
Pro1195 residue in the β chain of IrP1195L/wt mice. This muta-
tion corresponds to a homologous mutation substituting a
Leu1178 for the Pro1178 residue of the human IR in patients
with type A insulin resistance found in Japanese and British
patients [39, 40]. A Japanese patient with the orthologous
mutation showed obesity, moderate insulin resistance, acan-
thosisnigricans,andhyperandrogenismwithnormalglucose
tolerance [39]. The authors of that paper suggested that
insulin resistance and the other clinical features observed in
the patient were due to obesity rather than the mutation
in the IR gene [39]. Interestingly, Krook et al. reported
that a type A Cam-3 patient with an orthologous mutation
presented with oligomenorrhea, hirsutism, and acanthosis
nigricans at 13 years of age [40]. She subsequently developed
hyperglycemia. Moreover, the authors described in this
paper that the patient had inherited the IR mutation from
her father, who was clinically normal but had a moderate
elevation of his fasting insulin. The patient’s mother and
sister also had moderate hyperinsulinemia, which suggests
that there was a second defect in this patient [40]. In
this context, we speculated that there was a heterozygous
mutation in the father or mother of the British patient who
had hyperinsulinemia without developing hyperglycemia,
while the second defect in the patient led to severe insulin
resistance and hyperglycemia. Based on these reports and
our present data, we suggested that the heterozygosity of the
orthologous mutation with the kinase domain of the IR gene
leads to moderate insulin resistance with hyperinsulinemia,
but does not lead to the development of hyperglycaemia in
mice or humans.
Kido et al. reported that genetic modiﬁers of insulin
resistance inﬂuence the phenotype in IR-deﬁcient mice [41].
On the genetic background of B6 mice, the haploinsuf-
ﬁciency of the IR gene caused mild hyperinsulinemia. In
contrast, on the genetic background of 129/Sv mice, the
same mutation caused severe hyperinsulinemia, suggesting
that the 129/Sv strain harbors alleles that interact with the
IR mutation and predispose these mice to insulin resistance
[41]. Interestingly, these data were obtained for males,
while females did not develop hyperinsulinemia on either
background.Thesestudiesalsoindicatedthat5-10%ofIR+/−
mice on the B6 background developed hyperglycemia, while
25% of IR+/− mice on the 129/Sv background developed
hyperglycemia [41, 42]. Thus, the B6 strain is relatively
resistant to the deleterious eﬀects of the haploinsuﬃciency of
the IR gene. Since we developed our IrP1195L/wt mice on a B6
genetic background, further analyses in mice of a diﬀerent
background may provide us with information about the
genetic modiﬁer(s) and help evaluate the pathological eﬀects
of the IR mutation on the development of hyperglycemia.
5. Conclusion
In the present study, we showed that IrP1195L/wt mice showed
a normal lifespan, as well as hyperinsulinemia, and they
did not develop hyperglycemia throughout their lifespan.
This study provides evidence that insulin signaling does
not make a major contribution to regulating the lifespan
in mammals. A further analysis of altered insulin signaling
using IrP1195L/wt mice, especially those developed on another
background, should provide us with a useful strategy for the
prevention of age-associated diseases, such as type 2 DM in
humans.
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